Oligodendroglioma (patient information): Difference between revisions
No edit summary |
m (Robot: Changing Category:Disease state to Category:Disease) |
||
Line 19: | Line 19: | ||
{{SIB}} | {{SIB}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Disease | [[Category:Disease]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
Line 26: | Line 28: | ||
[[Category:Neurology patient information]] | [[Category:Neurology patient information]] | ||
[[Category:Oncology patient information]] | [[Category:Oncology patient information]] | ||
Revision as of 22:08, 9 December 2011
For the WikiDoc page for this topic, click here
Editor-in-Chief: C. Michael Gibson, M.S.,M.D. [1] Phone:617-632-7753; Associate Editor-In-Chief: Jinhui Wu, MD
Overview
Oligodendroglioma is a type of glioma. It occupies about 4% of brain tumors. This type of brain tumor origins from the oligodendrocytes which make myelin, a substance that surrounds and insulates axons of the brain and spinal cord. Oligodendroglioma occurs primarily in adults and only rarely found in children. Usual symptoms include headache, hydrocephalus, nausea and vomiting, seizure, weakness, or numbness in the extremities. Sometimes oligodendroglioma may spread along the cerebrospinal fluid pathways but rarely spread outside the brain or spinal cord. Treatments include surgery, radiation therapy, chemotherapy, gene therapy, or a combination of them. Because oligodendroglioma may infiltrate nearby brain tissue, it cannot be completely removed by surgery. Prognosis of oligodendroglioma depends on the grade of the cancer.
See also
Where to find medical care for oligodendroglioma?
Directions to Hospitals Treating oligodendroglioma